Rhythm or rate control in atrial fibrillation - Pharmacological intervention in atrial fibrillation (PIAF): A randomised trial

Lancet

Volumn 356, Issue 9244, 2000, Pages 1789-1794

  Hohnloser, Stefan H ^a   Kuck, Karl Heinz ^b   Lilienthal, Jürgen ^c  

^a GOETHE UNIVERSITY   (Germany)

^b St George's Hospital   (United Kingdom)

^c Datamap GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DILTIAZEM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; EXERCISE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0034715973     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03230-X     Document Type: Article

References (28)

1. Independent risk factors for atrial fibrillation in a population-base cohort: The Framingham Heart Study
2. Hospitalizations for arrhythmias in the United States: Importance of atrial fibrillation
3. Atrial fibrillation: Restoration and maintenance of sinus rhythm and indications for anticoagulation therapy
4. New method for terminating cardiac arrhythmias - Use of synchronized capacitor discharge
5. Atrial fibrillation: Current knowledge and recommendations for management
6. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials
7. Proarrhythmia with class III antiarrhythmic drugs: Definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications
8. Atrial fibrillation. Mainenance of sinus rhthm versus rate control
9. Atrial fibrillation: Maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: The PIAF trial
10. The MOS 36-item short-form health survey (SF-36), II: Psychometric and clinical tests validity in measuring physical and mental health constructs
11. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily life in patients with recurrent arrhythmia
12. Quality of life in patients with supraventricular arrhythmia
13. Impact of atrial fibrillation on quality of life: A prospective, multicenter study
14. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring study
15. Atrial fibrillation with and without heart disease: Clinical characteristics and proarrhythmia risk
16. Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study
17. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: A randomized controlled study
18. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular modification in patients with medically refractory atrial fibrillation
19. Indications and limitations of class II and III antiarrhythmic drugs in atrial fibrillation
20. Ventricular rate control and exercise performance in chronic atrial fibrillation: Effects of diltiazem and verapamil
21. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators
22. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
23. A randomized comparison of antiarrhythmic drug therapy with implantable defibrillators resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH)
24. Amiodarone-associated pro-arrhythmic effects: A review with special reference to torsade de pointes tachycardia
25. The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation
26. Functional capacity before and after cardioversion of atrial fibrillation: A controlled study
27. The case for inpatient initiation of antiarrythmic therapy
28. Atrial fibrillation follow-up investigation of rhythm management - The AFFIRM study design